Company: MIRM
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001759425-25-000022
Chunk: 80

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 80
---
 on our website, all of our filings that are made electronically with the SEC, including Forms 10-K, 10-Q and 8-K. To access these filings, go to our website ir.mirumpharma.com . The information on our website is not incorporated by reference into this Proxy Statement or the Annual Report. Copies of our Annual Report, including financial statements and schedules thereto, filed with the SEC, are also available without charge to stockholders upon written request to: 989 East Hillsdale Boulevard, Suite 300, Foster City, California 94404, Attention: Corporate Secretary.

#### 64Mirum Pharmaceuticals2025 Proxy Statement

### TABLE OF CONTENTS
| Other Matters |

The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, the proxy holders have discretionary authority to vote all proxies in accordance with their best judgment. Discretionary authority for them to do so is provided for in the proxy card and other forms of proxy.

By Order of the Board of Directors

#### Christopher Peetz
Chief Executive Officer

April 14, 2025

#### Mirum Pharmaceuticals2025 Proxy Statement65